Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 532538 | NSE: ULTRACEMCO

UltraTech Cement Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 10:07 am

Market Cap 3,05,517 Cr.
Current Price 10,582
High / Low 12,145/9,250
Stock P/E48.7
Book Value 2,126
Dividend Yield0.66 %
ROCE15.1 %
ROE12.2 %
Face Value 10.0
PEG Ratio18.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for UltraTech Cement Ltd

Competitors of UltraTech Cement Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Bheema Cements Ltd 52.7 Cr. 16.2 35.3/16.2 13.20.00 %11.8 %56.4 % 10.0
UltraTech Cement Ltd 3,05,517 Cr. 10,582 12,145/9,25048.7 2,1260.66 %15.1 %12.2 % 10.0
The Ramco Cements Ltd 20,596 Cr. 872 1,060/700108 3020.29 %8.17 %5.63 % 1.00
The India Cements Ltd 9,204 Cr. 297 386/173 1700.00 %0.78 %4.81 % 10.0
Star Cement Ltd 8,676 Cr. 215 256/17265.0 67.90.00 %16.5 %11.5 % 1.00
Industry Average34,145.38 Cr1,855.5045.46529.570.67%11.18%15.93%7.13

All Competitor Stocks of UltraTech Cement Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 12,98515,76715,16413,89315,52118,66217,73716,01216,74020,41918,07015,63517,193
Expenses 10,56612,69512,06912,02813,18515,34014,68813,46113,48516,30515,03013,61814,307
Operating Profit 2,4193,0733,0951,8652,3363,3223,0492,5513,2554,1143,0392,0172,886
OPM % 19%19%20%13%15%18%17%16%19%20%17%13%17%
Other Income 7125311014613012317717114673201221244
Interest 182206216200215191211234262261256317382
Depreciation 674703695708723762749798783815843904917
Profit before tax 1,6342,4162,2931,1031,5272,4922,2671,6902,3553,1112,1421,0171,832
Tax % -5%-8%31%31%30%33%25%24%25%27%21%19%20%
Net Profit 1,7102,6141,5827591,0631,6701,6901,2801,7752,2591,6958251,474
EPS in Rs 59.1690.7854.8726.1836.6657.7158.4944.3961.5578.2258.7728.4050.90

Last Updated: February 27, 2025, 11:27 pm

Below is a detailed analysis of the quarterly data for UltraTech Cement Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹17,193.00 Cr.. The value appears strong and on an upward trend. It has increased from 15,635.00 Cr. (Sep 2024) to ₹17,193.00 Cr., marking an increase of ₹1,558.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹14,307.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13,618.00 Cr. (Sep 2024) to ₹14,307.00 Cr., marking an increase of ₹689.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹2,886.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,017.00 Cr. (Sep 2024) to ₹2,886.00 Cr., marking an increase of ₹869.00 Cr..
  • For OPM %, as of Dec 2024, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Sep 2024) to 17.00%, marking an increase of 4.00%.
  • For Other Income, as of Dec 2024, the value is ₹244.00 Cr.. The value appears strong and on an upward trend. It has increased from 221.00 Cr. (Sep 2024) to ₹244.00 Cr., marking an increase of ₹23.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹382.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 317.00 Cr. (Sep 2024) to ₹382.00 Cr., marking an increase of ₹65.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹917.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 904.00 Cr. (Sep 2024) to ₹917.00 Cr., marking an increase of ₹13.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹1,832.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,017.00 Cr. (Sep 2024) to ₹1,832.00 Cr., marking an increase of ₹815.00 Cr..
  • For Tax %, as of Dec 2024, the value is 20.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Sep 2024) to 20.00%, marking an increase of 1.00%.
  • For Net Profit, as of Dec 2024, the value is ₹1,474.00 Cr.. The value appears strong and on an upward trend. It has increased from 825.00 Cr. (Sep 2024) to ₹1,474.00 Cr., marking an increase of ₹649.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 50.90. The value appears strong and on an upward trend. It has increased from ₹28.40 (Sep 2024) to 50.90, marking an increase of ₹22.50.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:30 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 20,51420,73023,30625,15325,37530,97941,46242,43044,72652,59963,24070,90871,317
Expenses 15,67416,69518,88120,25220,16224,83434,11533,18433,15841,08452,62057,94059,261
Operating Profit 4,8394,0354,4254,9015,2126,1457,3479,24611,56811,51410,62012,96912,056
OPM % 24%19%19%19%21%20%18%22%26%22%17%18%17%
Other Income 304322350464648242350651619669507567739
Interest 2523615875666401,2381,7781,9921,4869458239681,216
Depreciation 1,0231,1391,2031,3771,3481,8482,4512,7232,7002,7152,8883,1453,478
Profit before tax 3,8672,8582,9863,4213,8723,3013,4685,1838,0018,5247,4169,4228,101
Tax % 30%23%30%28%30%33%31%-11%32%14%32%26%
Net Profit 2,6882,2132,1022,4802,7142,2242,4005,7515,4627,3345,0737,0046,252
EPS in Rs 97.6680.4476.4790.3098.9080.9287.51199.40189.26254.42175.41242.65216.29
Dividend Payout % 9%11%12%11%10%13%13%7%20%15%22%29%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-17.67%-5.02%17.98%9.44%-18.05%7.91%139.62%-5.03%34.27%-30.83%38.06%
Change in YoY Net Profit Growth (%)0.00%12.66%23.00%-8.55%-27.49%25.97%131.71%-144.65%39.30%-65.10%68.89%

UltraTech Cement Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:13%
5 Years:11%
3 Years:17%
TTM:3%
Compounded Profit Growth
10 Years:13%
5 Years:24%
3 Years:8%
TTM:-2%
Stock Price CAGR
10 Years:13%
5 Years:22%
3 Years:20%
1 Year:9%
Return on Equity
10 Years:12%
5 Years:13%
3 Years:12%
Last Year:12%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 6:39 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 274274274274275275275289289289289289289
Reserves 14,95516,90818,76721,67124,11726,10733,47638,75543,88650,14754,03659,93961,076
Borrowings 7,3427,3329,82910,6168,47419,48025,33723,01921,71911,29911,05811,40316,964
Other Liabilities 7,0107,6719,1838,6319,34311,28017,43817,15120,28222,07725,99829,16729,282
Total Liabilities 29,58232,18538,05341,19342,20957,14176,52579,21486,17683,81191,380100,797107,611
Fixed Assets 15,05018,10023,34325,30925,90439,71556,64557,15155,41255,48859,57962,87868,042
CWIP 3,6012,1862,2501,4699211,5111,1539201,6874,7854,0406,8116,410
Investments 4,7094,8624,5005,0956,6915,4472,9215,92912,1786,3367,2978,2497,579
Other Assets 6,2227,0377,9619,3198,69310,46815,80615,21516,90017,20320,46422,85925,579
Total Assets 29,58232,18538,05341,19342,20957,14176,52579,21486,17683,81191,380100,797107,611

Below is a detailed analysis of the balance sheet data for UltraTech Cement Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹289.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹289.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹61,076.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹59,939.00 Cr. (Mar 2024) to ₹61,076.00 Cr., marking an increase of 1,137.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹16,964.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹11,403.00 Cr. (Mar 2024) to ₹16,964.00 Cr., marking an increase of 5,561.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹29,282.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹29,167.00 Cr. (Mar 2024) to ₹29,282.00 Cr., marking an increase of 115.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹107,611.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹100,797.00 Cr. (Mar 2024) to ₹107,611.00 Cr., marking an increase of 6,814.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹68,042.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹62,878.00 Cr. (Mar 2024) to ₹68,042.00 Cr., marking an increase of 5,164.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹6,410.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹6,811.00 Cr. (Mar 2024) to ₹6,410.00 Cr., marking a decrease of 401.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹7,579.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹8,249.00 Cr. (Mar 2024) to ₹7,579.00 Cr., marking a decrease of 670.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹25,579.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹22,859.00 Cr. (Mar 2024) to ₹25,579.00 Cr., marking an increase of 2,720.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹107,611.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹100,797.00 Cr. (Mar 2024) to ₹107,611.00 Cr., marking an increase of 6,814.00 Cr..

Notably, the Reserves (₹61,076.00 Cr.) exceed the Borrowings (16,964.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +3,6183,4554,1904,5265,0053,8885,9568,97212,5009,2839,06910,898
Cash from Investing Activity +-4,362-2,342-2,144-3,673-2,5011,8661,165-4,192-8,8562,257-7,188-8,789
Cash from Financing Activity +715-949-2,110-844-2,535-5,735-6,757-5,076-4,356-12,498-1,631-1,926
Net Cash Flow-30164-638-3118364-295-712-958250183

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-3.00-3.00-5.00-6.00-3.00-13.00-18.00-14.00-10.000.00-1.001.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days242926282526252021212222
Inventory Days284251266203195226214234207256248255
Days Payable258252154142150165165188234269271260
Cash Conversion Cycle50281388970877466-69-017
Working Capital Days-15-2-42-47-23-17-16-25-26-21-29-25
ROCE %19%12%12%13%14%12%10%12%15%14%13%15%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters59.96%59.96%59.96%59.96%59.96%59.96%59.96%59.96%59.96%59.96%59.98%59.99%
FIIs15.74%14.03%13.12%14.06%14.11%14.77%15.81%16.65%18.20%17.74%18.15%17.95%
DIIs15.15%16.39%18.16%17.30%17.40%16.93%15.95%15.04%13.68%14.14%13.83%14.08%
Government0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%
Public9.00%9.48%8.62%8.50%8.35%8.14%8.09%8.11%7.95%7.92%7.82%7.75%
Others0.10%0.09%0.09%0.14%0.13%0.15%0.14%0.18%0.18%0.17%0.17%0.17%
No. of Shareholders3,31,3193,95,9724,33,1964,15,4033,83,9713,66,4373,49,2813,47,9043,42,4223,57,6273,53,5653,56,405

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Bluechip Fund2,150,6334.232509.34641,2612025-03-10235.38%
SBI Nifty 50 ETF2,098,5371.262448.55641,2612025-03-10227.25%
Kotak Flexicap Fund - Regular Plan1,800,0004.112100.22641,2612025-03-10180.7%
SBI BSE Sensex ETF1,508,5391.481759.15641,2612025-03-10135.25%
Axis Bluechip Fund691,3682.34806.68641,2612025-03-107.81%
SBI Blue Chip Fund641,2611.52748.22641,2612025-03-100%
UTI Nifty 50 ETF606,4721.26707.63641,2612025-03-10-5.43%
UTI BSE Sensex ETF552,0231.48643.73641,2612025-03-10-13.92%
ICICI Prudential Balanced Advantage Fund519,8261.04606.53641,2612025-03-10-18.94%
ICICI Prudential Business Cycle Fund486,9985.21568.22641,2612025-03-10-24.06%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 243.05175.63254.64189.40199.55
Diluted EPS (Rs.) 242.87175.54254.53189.33199.49
Cash EPS (Rs.) 350.80275.64348.06282.69293.62
Book Value[Excl.RevalReserv]/Share (Rs.) 2088.171883.691747.051530.591352.99
Book Value[Incl.RevalReserv]/Share (Rs.) 2088.171883.691747.051530.591352.99
Revenue From Operations / Share (Rs.) 2456.202190.581822.111549.481470.04
PBDIT / Share (Rs.) 470.59385.29416.47426.19342.94
PBIT / Share (Rs.) 361.64285.25322.42332.65248.61
PBT / Share (Rs.) 325.62256.75289.70272.14179.60
Net Profit / Share (Rs.) 241.85175.60254.01189.14199.29
NP After MI And SOA / Share (Rs.) 242.65175.41254.42189.26199.40
PBDIT Margin (%) 19.1517.5822.8527.5023.32
PBIT Margin (%) 14.7213.0217.6921.4616.91
PBT Margin (%) 13.2511.7215.8917.5612.21
Net Profit Margin (%) 9.848.0113.9412.2013.55
NP After MI And SOA Margin (%) 9.878.0013.9612.2113.56
Return on Networth / Equity (%) 11.639.3214.5612.3614.74
Return on Capital Employeed (%) 14.1212.1114.6114.6311.45
Return On Assets (%) 6.945.548.766.337.26
Long Term Debt / Equity (X) 0.080.090.100.300.44
Total Debt / Equity (X) 0.170.180.200.400.54
Asset Turnover Ratio (%) 0.730.710.600.540.54
Current Ratio (X) 0.860.880.861.170.88
Quick Ratio (X) 0.550.600.590.970.63
Inventory Turnover Ratio (X) 1.371.461.411.311.25
Dividend Payout Ratio (NP) (%) 15.6321.5714.526.866.61
Dividend Payout Ratio (CP) (%) 10.7813.7410.604.594.48
Earning Retention Ratio (%) 84.3778.4385.4893.1493.39
Cash Earning Retention Ratio (%) 89.2286.2689.4095.4195.52
Interest Coverage Ratio (X) 14.0313.5212.738.284.97
Interest Coverage Ratio (Post Tax) (X) 8.297.168.594.753.89
Enterprise Value (Cr.) 290900.97228788.60200424.86210253.91114868.67
EV / Net Operating Revenue (X) 4.103.623.814.702.71
EV / EBITDA (X) 21.4120.5716.6717.0911.60
MarketCap / Net Operating Revenue (X) 3.973.483.624.352.21
Retention Ratios (%) 84.3678.4285.4793.1393.38
Price / BV (X) 4.674.053.784.402.41
Price / Net Operating Revenue (X) 3.973.483.624.352.21
EarningsYield 0.020.020.030.020.06

After reviewing the key financial ratios for UltraTech Cement Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 243.05. This value is within the healthy range. It has increased from 175.63 (Mar 23) to 243.05, marking an increase of 67.42.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 242.87. This value is within the healthy range. It has increased from 175.54 (Mar 23) to 242.87, marking an increase of 67.33.
  • For Cash EPS (Rs.), as of Mar 24, the value is 350.80. This value is within the healthy range. It has increased from 275.64 (Mar 23) to 350.80, marking an increase of 75.16.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 2,088.17. It has increased from 1,883.69 (Mar 23) to 2,088.17, marking an increase of 204.48.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 2,088.17. It has increased from 1,883.69 (Mar 23) to 2,088.17, marking an increase of 204.48.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 2,456.20. It has increased from 2,190.58 (Mar 23) to 2,456.20, marking an increase of 265.62.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 470.59. This value is within the healthy range. It has increased from 385.29 (Mar 23) to 470.59, marking an increase of 85.30.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 361.64. This value is within the healthy range. It has increased from 285.25 (Mar 23) to 361.64, marking an increase of 76.39.
  • For PBT / Share (Rs.), as of Mar 24, the value is 325.62. This value is within the healthy range. It has increased from 256.75 (Mar 23) to 325.62, marking an increase of 68.87.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 241.85. This value is within the healthy range. It has increased from 175.60 (Mar 23) to 241.85, marking an increase of 66.25.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 242.65. This value is within the healthy range. It has increased from 175.41 (Mar 23) to 242.65, marking an increase of 67.24.
  • For PBDIT Margin (%), as of Mar 24, the value is 19.15. This value is within the healthy range. It has increased from 17.58 (Mar 23) to 19.15, marking an increase of 1.57.
  • For PBIT Margin (%), as of Mar 24, the value is 14.72. This value is within the healthy range. It has increased from 13.02 (Mar 23) to 14.72, marking an increase of 1.70.
  • For PBT Margin (%), as of Mar 24, the value is 13.25. This value is within the healthy range. It has increased from 11.72 (Mar 23) to 13.25, marking an increase of 1.53.
  • For Net Profit Margin (%), as of Mar 24, the value is 9.84. This value is within the healthy range. It has increased from 8.01 (Mar 23) to 9.84, marking an increase of 1.83.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.87. This value is within the healthy range. It has increased from 8.00 (Mar 23) to 9.87, marking an increase of 1.87.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 11.63. This value is below the healthy minimum of 15. It has increased from 9.32 (Mar 23) to 11.63, marking an increase of 2.31.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 14.12. This value is within the healthy range. It has increased from 12.11 (Mar 23) to 14.12, marking an increase of 2.01.
  • For Return On Assets (%), as of Mar 24, the value is 6.94. This value is within the healthy range. It has increased from 5.54 (Mar 23) to 6.94, marking an increase of 1.40.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.17. This value is within the healthy range. It has decreased from 0.18 (Mar 23) to 0.17, marking a decrease of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.73. It has increased from 0.71 (Mar 23) to 0.73, marking an increase of 0.02.
  • For Current Ratio (X), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 1.5. It has decreased from 0.88 (Mar 23) to 0.86, marking a decrease of 0.02.
  • For Quick Ratio (X), as of Mar 24, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.60 (Mar 23) to 0.55, marking a decrease of 0.05.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.37. This value is below the healthy minimum of 4. It has decreased from 1.46 (Mar 23) to 1.37, marking a decrease of 0.09.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 15.63. This value is below the healthy minimum of 20. It has decreased from 21.57 (Mar 23) to 15.63, marking a decrease of 5.94.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 10.78. This value is below the healthy minimum of 20. It has decreased from 13.74 (Mar 23) to 10.78, marking a decrease of 2.96.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 84.37. This value exceeds the healthy maximum of 70. It has increased from 78.43 (Mar 23) to 84.37, marking an increase of 5.94.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 89.22. This value exceeds the healthy maximum of 70. It has increased from 86.26 (Mar 23) to 89.22, marking an increase of 2.96.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 14.03. This value is within the healthy range. It has increased from 13.52 (Mar 23) to 14.03, marking an increase of 0.51.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 8.29. This value is within the healthy range. It has increased from 7.16 (Mar 23) to 8.29, marking an increase of 1.13.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 290,900.97. It has increased from 228,788.60 (Mar 23) to 290,900.97, marking an increase of 62,112.37.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.10. This value exceeds the healthy maximum of 3. It has increased from 3.62 (Mar 23) to 4.10, marking an increase of 0.48.
  • For EV / EBITDA (X), as of Mar 24, the value is 21.41. This value exceeds the healthy maximum of 15. It has increased from 20.57 (Mar 23) to 21.41, marking an increase of 0.84.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.97. This value exceeds the healthy maximum of 3. It has increased from 3.48 (Mar 23) to 3.97, marking an increase of 0.49.
  • For Retention Ratios (%), as of Mar 24, the value is 84.36. This value exceeds the healthy maximum of 70. It has increased from 78.42 (Mar 23) to 84.36, marking an increase of 5.94.
  • For Price / BV (X), as of Mar 24, the value is 4.67. This value exceeds the healthy maximum of 3. It has increased from 4.05 (Mar 23) to 4.67, marking an increase of 0.62.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.97. This value exceeds the healthy maximum of 3. It has increased from 3.48 (Mar 23) to 3.97, marking an increase of 0.49.
  • For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of UltraTech Cement Ltd as of March 12, 2025 is: ₹10,171.83

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, UltraTech Cement Ltd is Overvalued by 3.88% compared to the current share price 10,582.00

Intrinsic Value of UltraTech Cement Ltd as of March 12, 2025 is: 10,447.07

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, UltraTech Cement Ltd is Overvalued by 1.28% compared to the current share price 10,582.00

Last 5 Year EPS CAGR: 2.71%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -24.00, which is a positive sign.
  2. The company has higher reserves (35,680.00 cr) compared to borrowings (14,144.00 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (40.46 cr) and profit (4.92 cr) over the years.
  1. The stock has a low average ROCE of 13.42%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 51.83, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UltraTech Cement Ltd:
    1. Net Profit Margin: 9.84%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 14.12% (Industry Average ROCE: 11.18%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 11.63% (Industry Average ROE: 15.93%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 8.29
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.55
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 48.7 (Industry average Stock P/E: 45.46)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.17
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

UltraTech Cement Ltd. is a Public Limited Listed company incorporated on 24/08/2000 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L26940MH2000PLC128420 and registration number is 128420. Currently Company is involved in the business activities of Manufacture of cement, lime and plaster. Company's Total Operating Revenue is Rs. 68640.63 Cr. and Equity Capital is Rs. 288.69 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Cement'B' Wing, Ahura Centre, 2nd Foor, Mumbai Maharashtra 400093sharesutcl@adityabirla.com
http://www.ultratechcement.com
Management
NamePosition Held
Mr. Kumar Mangalam BirlaChairman
Mr. K K MaheshwariVice Chairman & Non Exe.Dire
Mr. K C JhanwarManaging Director
Mr. Atul DagaWholeTime Director & CFO
Mrs. Rajashree BirlaNon Executive Director
Mr. Arun AdhikariIndependent Director
Mrs. Alka BharuchaIndependent Director
Mr. Sunil DuggalIndependent Director
Mrs. Sukanya KripaluIndependent Director
Mr. S B MathurIndependent Director

FAQ

What is the latest intrinsic value of UltraTech Cement Ltd?

The latest intrinsic value of UltraTech Cement Ltd as on 09 March 2025 is ₹10171.83, which is 3.88% lower than the current market price of 10,582.00, indicating the stock is overvalued by 3.88%. The intrinsic value of UltraTech Cement Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹3,05,517 Cr. and recorded a high/low of ₹12,145/9,250 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹61,076 Cr and total liabilities of ₹107,611 Cr.

What is the Market Cap of UltraTech Cement Ltd?

The Market Cap of UltraTech Cement Ltd is 3,05,517 Cr..

What is the current Stock Price of UltraTech Cement Ltd as on 09 March 2025?

The current stock price of UltraTech Cement Ltd as on 09 March 2025 is ₹10,582.

What is the High / Low of UltraTech Cement Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of UltraTech Cement Ltd stocks is ₹12,145/9,250.

What is the Stock P/E of UltraTech Cement Ltd?

The Stock P/E of UltraTech Cement Ltd is 48.7.

What is the Book Value of UltraTech Cement Ltd?

The Book Value of UltraTech Cement Ltd is 2,126.

What is the Dividend Yield of UltraTech Cement Ltd?

The Dividend Yield of UltraTech Cement Ltd is 0.66 %.

What is the ROCE of UltraTech Cement Ltd?

The ROCE of UltraTech Cement Ltd is 15.1 %.

What is the ROE of UltraTech Cement Ltd?

The ROE of UltraTech Cement Ltd is 12.2 %.

What is the Face Value of UltraTech Cement Ltd?

The Face Value of UltraTech Cement Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in UltraTech Cement Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE